This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
srbtkanalyst.bsky.social
did:plc:rj4htbtw2ycymfhclnkd2a6j
It also provides clarity for drugs that transition out of orphan status, delaying price negotiation until they are no longer used solely for rare diseases. This change is likely to restore incentives for developing additional indications for orphan drugs, benefiting both patients and manufacturers."
2025-06-28T15:52:10.638Z